EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H24N2O2 |
| Net Charge | 0 |
| Average Mass | 324.424 |
| Monoisotopic Mass | 324.18378 |
| SMILES | [H][C@@]1([C@H](O)c2ccnc3ccc(OC)cc23)C[C@@H]2CC[N@@]1C[C@@H]2C=C |
| InChI | InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1 |
| InChIKey | LOUPRKONTZGTKE-WZBLMQSHSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. muscle relaxant A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| quinine (CHEBI:15854) has parent hydride (8S)-cinchonan (CHEBI:59138) |
| quinine (CHEBI:15854) has role antimalarial (CHEBI:38068) |
| quinine (CHEBI:15854) has role muscle relaxant (CHEBI:51371) |
| quinine (CHEBI:15854) has role non-narcotic analgesic (CHEBI:35481) |
| quinine (CHEBI:15854) is a cinchona alkaloid (CHEBI:51323) |
| quinine (CHEBI:15854) is conjugate base of quinine(1+) (CHEBI:137041) |
| Incoming Relation(s) |
| 3-hydroxyquinine (CHEBI:17685) has functional parent quinine (CHEBI:15854) |
| quinine sulfate (CHEBI:52250) has part quinine (CHEBI:15854) |
| quinine(1+) (CHEBI:137041) is conjugate acid of quinine (CHEBI:15854) |
| quininyl group (CHEBI:52903) is substituent group from quinine (CHEBI:15854) |
| IUPAC Name |
|---|
| (9R)-6'-methoxy-8α-cinchonan-9-ol |
| Synonyms | Source |
|---|---|
| Quinine | KEGG COMPOUND |
| Chinin | ChemIDplus |
| (8S,9R)-quinine | NIST Chemistry WebBook |
| (−)-quinine | ChemIDplus |
| quinina | ChEBI |
| chininum | ChEBI |
| Citations |
|---|